Inflammation and immunothrombosis in cerebral cavernous malformation: Novel molecular targets for the treatment of an incurable disease

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: id:"swepub:oai:DiVA.org:uu-501400" > Inflammation and im...

1 of 1
Previous record
Next record
To hitlist

Details
MARC

Globisch, Maria AscenciónUppsala universitet,Vaskulärbiologi (author)

Inflammation and immunothrombosis in cerebral cavernous malformation : Novel molecular targets for the treatment of an incurable disease

BookEnglish2023

Publisher, publication year, extent ...

Uppsala :Acta Universitatis Upsaliensis,2023
50 s.
electronicrdacarrier

Numbers

LIBRIS-ID:oai:DiVA.org:uu-501400
ISBN:9789151318264
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-501400URI

Supplementary language notes

Language:English
Summary in:English &language:-1_t

Part of subdatabase

SwePubSwePub

Classification

Subject category:vet swepub-contenttype
Subject category:dok swepub-publicationtype

Series

Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine,1651-6206 ;1953

Notes

Cerebral cavernous malformation (CCM) is a vascular disease that causes mulberry-like lesions (cavernomas) in the central nervous system (CNS). Cavernomas are fragile, leaky and prone to rupture which may cause symptoms such as epileptic seizures, focal neurological deficits and hemorrhagic strokes. CCM lesions can appear sporadically in 0.5% of the general population. Alternatively, CCM lesions appear as a consequence of a loss-of-function germline mutation in either CCM1, CCM2, or CCM3 in endothelial cells of the CNS. Inherited CCM is termed familial, and it affects approximately one in ten thousand individuals in an autosomal dominant manner. The aim of this thesis project is to identify novel cell and molecular mechanisms that contribute to the development and progression of cavernous malformations. Additionally, this thesis project aims to identify and validate inhibitors that may reduce lesions and alleviate the side effects in CCM. In this thesis project, two inducible endothelial specific Ccm3 deficient mouse models (acute and chronic) were evaluated with methods such as RNA-sequencing, immunofluorescence, ELISA, scanning and transmission electron microscopy, flow cytometry, and in situ hybridization. Moreover, in vitro cell cultures were used with methods such as immunofluorescence, qPCR, and western blot. Importantly, sporadic and familial human CCM samples were used to show the clinical relevance of our studies. In paper I we focused on the role and kinetics of inflammation in CCM. We analyzed the transcriptome of healthy and Ccm3 deficient mouse brain endothelial cells and found that genes related to inflammation were upregulated in CCM pathology. We identified various inflammatory cytokines in vivo and also identified neutrophils as the most prominent immune cell subtype in CCM. Moreover, we found that neutrophils in CCM produce neutrophil extracellular traps (NETs), that can be inhibited with DNase I. The inhibition of NETs stabilized cavernoma vasculature by reducing fibrinogen and IgG leakage. In paper II we re-used the acute RNA-seq database from paper 1 and focused on endothelial hemostasis and hypoxia. We found that genes related to procoagulation, anticoagulation, and hypoxia were highly upregulated in Ccm3 deficient mice. We validated the findings in vivo and found that the hemostatic system in CCM is dysregulated and that it causes, bleeding, thrombosis, and cerebral hypoxia. In paper III we evaluated the effect of propranolol in CCM. We treated chronic CCM mice with the beta-blocker propranolol and found that propranolol was able to reduce lesions in the brains and retinas of CCM mice as well as reduce cadaverine leakage. Importantly, we identified endothelial plasmalemmal pits and a thick basal membrane between endothelial cells and pericytes, pathological features which reduced upon propranolol treatment. Altogether this thesis significantly contributes to the CCM field as it identified pathological features of cavernomas such as neutrophils with NETs, endothelial plasmalemmal pits, and polyhedrocytes. This thesis work also evaluated pharmacological inhibitors (DNase I and propranolol) in mouse models of CCM and supports the use of anticoagulant therapies in patients with CCM.

Subject headings and genre

Cavernoma
Inflammation
Coagulation
Blood-brain-barrier
Blood
Hypoxia
Propranolol
Biologi med inriktning mot molekylär immunologi
Biology with specialization in Molecular Immunology

Added entries (persons, corporate bodies, meetings, titles ...)

Magnusson, Peetra,Associate ProfessorUppsala universitet,Institutionen för immunologi, genetik och patologi (thesis advisor)
Dejana, Elisabetta,ProfessorUppsala universitet,Institutionen för immunologi, genetik och patologi (thesis advisor)
Jeansson, Marie,Associate ProfessorUppsala universitet,Institutionen för immunologi, genetik och patologi (thesis advisor)
Randi, Anna,ProfessorImperial College London, England (opponent)
Uppsala universitetVaskulärbiologi (creator_code:org_t)

Internet link

Find in a library

Inflammation and immunothrombosis in cerebral cavernous malformation Novel molec... (Search the publication in LIBRIS)

To the university's database

1 of 1
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Globisch, Maria ...; Magnusson, Peetr ...; Dejana, Elisabet ...; Jeansson, Marie, ...; Randi, Anna, Pro ...

Parts in the series: Digital Comprehe ...

By the university: Uppsala University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se